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SUPPLEMENTAL TABLE 3 Comparison of Results of Models Incorporating All 10 Sites Contributing Data to the SB Registry and Either the 8 sites With
the Highest Enrollment Percentage or the 5 sites With No Statistical Evidence of Enrollment Bias
Variable All 10 Sites 8 Sites 5 Sites
OR (95% CI) P OR (95% CI) P OR (95% CI) P
Bowel continence
Age group, y ,.0001a ,.0001a .0340a
5 to ,10b
10 to ,13 1.76 (1.24–2.49) 1.85 (1.22–2.82) 1.75 (1.03–2.96)
13 to ,18 2.36 (1.73–3.22) 2.46 (1.69–3.58) 1.76 (1.09–2.85)
18 to ,22 2.67 (1.83–3.89) 2.99 (1.90–4.70) 2.05 (1.17–3.58)
Gender
Maleb
Female 1.34 (1.05–1.70) .0192 1.67 (1.24–2.24) .0006 1.88 (1.29–2.72) .0009
Race/ethnicity .0007a .0114a .0098a
Otherb
Hispanic 0.75 (0.51–1.12) 0.79 (0.51–1.25) 0.63 (0.33–1.21)
Non-Hispanic black 0.38 (0.23–0.63) 0.43 (0.24–0.76) 0.38 (0.19–0.73)
Insurance
Any privateb
Nonprivate 0.50 (0.38–0.65) ,.0001 0.47 (0.34–0.64) ,.0001 0.55 (0.37–0.81) .0025
Level of lesion (1 missingQ:1 ) ,.0001a ,.0001a .0017a
Thoracicb
High-lumbar 1.51 (0.94–2.44) 2.12 (1.21–3.74) 1.98 (0.96–4.06)
Midlumbar 1.06 (0.73–1.54) 0.90 (0.57–1.42) 0.85 (0.48–1.51)
Low-lumbar 1.40 (0.91–2.17) 1.60 (0.96–2.69) 1.31 (0.69–2.48)
Sacral 2.34 (1.58–3.47) 2.69 (1.66–4.35) 2.53 (1.39–4.62)
SB type
Myelomeningoceleb
Nonmyelomeningocele 2.52 (1.75–3.62) ,.0001 2.48 (1.62–3.81) ,.0001 3.13 (1.81–5.42) ,.0001
Bladder continence
Age group, y ,.0001a ,.0001a .0009a
5 to ,10b
10 to ,13 1.33 (0.94–1.89) 1.31 (0.87–1.97) 1.41 (0.85–2.35)
13 to ,18 2.21 (1.63–2.99) 2.28 (1.59–3.26) 2.31 (1.45–3.66)
18 to ,22 2.27 (1.57–3.27) 2.43 (1.57–3.74) 2.42 (1.42–4.13)
Gender
Maleb
Female 1.25 (0.98–1.58) .0670 1.39 (1.04–1.84) .0241 1.74 (1.22–2.49) .0023
Race/ethnicity .0389a .0410a .0673a
Otherb
Hispanic 0.82 (0.55–1.20) 0.84 (0.54–1.30) 0.95 (0.53–1.72)
Non-Hispanic black 0.53 (0.32–0.88) 0.49 (0.28–0.86) 0.46 (0.24–0.89)
Insurance
Any privateb
Nonprivate 0.55 (0.42–0.72) ,.0001 0.56 (0.42–0.76) .0002 0.57 (0.39–0.82) .0029
Level of lesion (1 missing) .0027a .0243a .2773a
Thoracicb
High-lumbar 1.17 (0.73–1.90) 1.34 (0.77–2.35) 1.19 (0.58–2.41)
Midlumbar 1.13 (0.78–1.64) 1.13 (0.73–1.76) 1.00 (0.58–1.73)
Low-lumbar 1.16 (0.75–1.78) 1.15 (0.69–1.92) 1.08 (0.58–2.00)
Sacral 1.97 (1.34–2.90) 2.01 (1.26–3.20) 1.73 (0.97–3.08)
SB type
Myelomeningoceleb
Nonmyelomeningocele 1.83 (1.30–2.59) .0005 1.88 (1.26–2.81) .0020 2.16 (1.31–3.58) .0027
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SUPPLEMENTAL TABLE 3 Continued
Variable All 10 Sites 8 Sites 5 Sites
OR (95% CI) P OR (95% CI) P OR (95% CI) P
Mobility status
Age groups (yrs) .0277a .0581a .1319a
2 to ,5b
5 to ,10 1.67 (1.10–2.53) 1.86 (1.15–3.02) 1.27 (0.67–2.40)
10 to ,13 1.43 (0.88–2.34) 1.32 (0.75–2.33) 1.28 (0.62–2.65)
13 to ,18 1.03 (0.66–1.60) 1.04 (0.62–1.76) 0.64 (0.33–1.26)
18 to ,22 0.83 (0.48–1.44) 0.90 (0.47–1.71) 0.62 (0.28–1.35)
Gender
Maleb
Female 1.54 (1.14–2.08) .0049 1.86 (1.30–2.66) .0007 1.58 (1.00–2.48) .0505
Race/ethnicity .3894a .8003a .5427a
Otherb
Hispanic 1.32 (0.83–2.09) 1.11 (0.66–1.88) 1.41 (0.66–3.02)
Non-Hispanic black 1.32 (0.73–2.38) 1.22 (0.62–2.40) 1.35 (0.63–2.88)
Insurance
Any privateb
Nonprivate 0.68 (0.49–0.95) .0233 0.71 (0.49–1.03) .0722 0.63 (0.39–1.00) .0523
Level of lesion (1 missing) ,.0001a ,.0001a ,.0001a
Thoracicb 0.00 (0.00–0.01) 0.00 (0.00–0.01) 0.00 (0.00–0.01)
High-lumbar 0.02 (0.01–0.04) 0.01 (0.01–0.04) 0.01 (0.00–0.05)
Midlumbar 0.15 (0.10–0.24) 0.17 (0.10–0.29) 0.17 (0.09–0.33)
Low-lumbar
Sacral 4.34 (2.18–8.64) 4.19 (1.77 – 9.91) 2.66 (1.06 – 6.73)
SB type
Myelomeningoceleb
Nonmyelomeningocele 3.42 (1.98–5.91) ,.0001 3.63 (1.91–6.90) ,.0001 5.07 (2.15–11.99) .0002
Pressure sores
Age groups (yrs) ,.0001a ,.0001a ,.0001a
Younger than 2 0.11 (0.05–0.26) 0.11 (0.04–0.31) 0.11 (0.02 – 0.46)
2 to ,5 0.54 (0.33–0.89) 0.32 (0.16–0.63) 0.41 (0.18 – 0.93)
5 to ,10b
10 to ,13 1.49 (0.97–2.30) 1.45 (0.86–2.42) 1.22 (0.63 – 2.36)
13 to ,18 1.78 (1.22–2.58) 1.83 (1.16–2.87) 1.81 (1.02 – 3.21)
18 to ,22 1.86 (1.18–2.93) 1.53 (0.88–2.65) 1.58 (0.81 – 3.05)
Gender
Maleb
Female 0.87 (0.67–1.14) .3258 0.93 (0.68–1.28) .6608 1.07 (0.71–1.62) .7322
Race/ethnicity .4320a .4319a .4999a
Otherb
Hispanic 0.81 (0.53–1.25) 0.78 (0.49–1.26) 0.67 (0.33–1.37)
Non-Hispanic black 1.18 (0.73–1.92) 1.19 (0.70–2.04) 1.07 (0.58–1.97)
Insurance
Any privateb
Nonprivate 1.27 (0.95–1.71) .1069 1.34 (0.96–1.86) .0877 1.32 (0.86–2.03) .2064
Level of lesion (1 missing) ,.0001a ,.0001a .0019a
Thoracicb
High-lumbar 0.99 (0.60–1.61) 0.99 (0.57–1.74) 0.65 (0.29–1.46)
Midlumbar 1.04 (0.71–1.50) 1.12 (0.73–1.72) 1.21 (0.71–2.05)
Low-lumbar 0.63 (0.40–1.01) 0.55 (0.32–0.95) 0.55 (0.28–1.09)
Sacral 0.29 (0.18–0.47) 0.31 (0.17–0.55) 0.32 (0.15–0.67)
SB type
Myelomeningoceleb
Nonmyelomeningocele 0.82 (0.50–1.33) .4204 0.60 (0.33–1.10) .0986 0.54 (0.24–1.20) .1282
a Overall P value.
b Reference group.
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